Preparative chiral separations

Details Preparative chiral separations Preparative chiral separations

1999-11-24

2002-02-05

Warden, Jill (Department: 1743)

Chemistry: electrical and wave energy

Processes and products

Electrophoresis or electro-osmosis processes and electrolyte...

C204S450000

Reexamination Certificate

active

06344121

ABSTRACT:

FIELD OF THE INVENTION
The invention relates to methods for preparative chiral separation. More particularly, the present invention relates to continuous free-flow electrophoresis preparative chiral separation by addition of chiral auxiliary agent(s).
BACKGROUND OF THE INVENTION
Separation of enantiomers is an important topic to the pharmaceutical industry. Many of the drugs marketed in the U.S. have at least one chiral center (e.g., ibuprofen and propranolol). Of the 528 synthetically derived chiral drugs, 88% are sold as the racemic mixture. The biological activities and bioavailabilities of the enantiomers sometimes differ. Often, one enantiomer has the desired therapeutic activity whereas the other enantiomer causes undesirable side-effects and may limit drug efficacy or dosage. It is also possible for both enantiomers to have therapeutic value . . . just not for the same disease state. For example, (S)-verapamil is effective as a calcium channel blocker while (R)-verapamil produces cardiac side effects but has potential in reversing multiple drug resistance in cancer therapy. Thus, the development of economical methods for preparative and semipreparative scale chiral separations is highly desirable.
Chiral separations are commonly performed using chiral stationary phases by liquid chromatography (HPLC), first reported in the early 1980's. The last decade has seen the commercialization of many different types of chiral stationary phases for HPLC. Each of these chiral stationary phases is very successful at separating large numbers of enantiomers which, in many cases, are unresolvable using any other chiral stationary phase. However, a large number of chiral compounds are unresolvable using any of the existing chiral stationary phases. Chiral HPLC columns are more expensive and require more careful handling than conventional columns. Column deterioration often results from a loss of the bonded phase rather than decomposition or racemization of the chiral ligand. Once the chiral column has begun to deteriorate, it generally cannot be returned to its original performance levels. Lot-to-lot variability further hampers method development and large-scale chiral separations remains largely unexplored.
Incomplete understanding of the chiral recognition mechanisms for many of these chiral stationary phases hinders rapid method development. Mobile phase optimization for many chiral HPLC stationary phases is usually not a trivial problem. In conventional HPLC, the relationship between retention and mobile phase composition or column temperature is well-behaved. However, for many chiral stationary phases, normal phase type-behavior may result under very nonpolar mobile phase conditions and reversed-phase behavior under very polar conditions. Often, there is a narrow “window” of mobile phase conditions under which enantioselectivity is observed and these conditions are usually solute-specific. In contrast to achiral chromatography, there are no chiral TLC plates (except ligand exchange chiral plates) commercially available for scouting mobile phase conditions or likelihood of chiral separation. Thus, column and conditions selection is often reduced to identifying structurally similar analytes for which chiral chromatographic methods have been reported in the scientific literature or chromatographic supply catalogues, and adapting the method for the chiral pair to be resolved.
Preparative chromatography (prep LC), often the method of choice for preparative chiral separations, requires the availability of a suitable chiral stationary phase (CSP). Prep LC columns are also costly and are usually only commercially available on a “special order” basis. Lot-to-lot variability in the packing sorbent as well as non-linear adsorption isotherms (e.g., in situ generation of secondary “chiral phase” from sorbed enantiomer) arising from mixed mode adsorption complicate scale-up. In addition, the mode of chromatography (e.g., batch vs displacement vs recycling vs simulated moving bed) must be decided.
Bioavailability of drug substances dictates that the compounds be water soluble and many are ionized at physiological pH. The pK
a
's of many drugs are well outside the safe operating range for silica-based media (Table 1) and almost all chiral stationary phases currently available are on silica substrates.
Most prep chiral LC employs an organic mobile phase. Many underivatized chiral drugs have only limited solubility in these organic mobile phases. Thus, sample
TABLE 1
Examples of pK
a
's for various chiral drugs
Drug
Class
pK
a
albuterol
bronchodilator
9.3
bupivacaine
anesthetic
8.1
chloroquine
antimalarial
10.8, 8.4
chlorpheniramine
antihistamine
9.2
introduction for many native drugs onto preparative chiral chromatographic columns often requires that packing material be removed from the head of the column, the sample mechanically mixed with this packing material. This mixture is then added to the top of the column, a process which is not easily automated.
Alternative techniques such as counter-current and centrifugal partition chromatographic methods, while allowing chiral selector recovery, require considerable amounts of mobile phase. Stereospecific enzymatic degradation requires identification of a suitable enzyme and often, a complementary enzyme is not available. Enzymatic degradation often preferentially destroys one enantiomer which may have intrinsic value or serve as an internal standard or reference material.
Among the most successful of the liquid chromatographic reversed-phase chiral stationary phases have been the cyclodextrin-based phases. Under predominantly aqueous mobile phase conditions, the mechanism responsible for the chiral selectivity with these phases is thought to rely on inclusion complexation between a hydrophobic moiety of the chiral analyte and the interior of the cyclodextrin cavity. Preferential complexation between one optical isomer and the cyclodextrin results in enantiomeric separation. However, selectivities (&agr;) reported for native cyclodextrin phases in the reversed-phase mode are, in general, less than 2.0 perhaps as a consequence of the low surface concentration of the cyclodextrins (e.g., 0.2-0.3 &mgr;mol/m
2
).
Classically, electrophoresis has been applied to the separation of charged materials such as proteins, nucleic acids, and cells. The separations depend upon differences in charge density and size. Capillary electrophoresis is a well-known technique for the analytical scale separation of chemical components. A sample solution containing molecules to be separated is introduced at one end of a length of capillary tubing containing an electrophoretic medium. Upon application of an electric field across the capillary, different components within the sample migrate at distinct rates towards the oppositely charged end of the capillary dependent upon their relative electrophoretic mobilities in the electrophoretic medium. Due to the varying electromigratory rates, the sample components become increasingly separated into distinct zones or groups as they progress along the capillary. At some position along the capillary, the components of the sample are detected. For example, U.S. Pat. No. 5,061,361 relates to a capillary zone electrophoresis system in which a nanoliter volume of sample is introduced into the capillary tube, and an electric field is imposed on the system to effect separation of the charged components. After migration along the length of the tube, the sample components are detected via ultra-violet absorbance. U.S. Pat. No. 5,084,150 relates to an electrokinetic method of separation in which the surface of moving charged colloidal particles is treated so as to interact selectively with the sample molecules to be separated. The above-described U.S. patents are hereby incorporated by reference.
Recently, capillary electrophoresis (CE) has been shown effective for chiral separations. Chiral separations by CE are usually accomplished using chiral additives in the run buffer. This approach offers several advantages (e.g., additive

Affiliated with

Also associated with

Rating

Preparative chiral separations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preparative chiral separations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparative chiral separations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2959247